The United States represents the dominant share of the North American lacrimal duct stent tube market. Factors such as a growing aging population, rising prevalence of chronic eye diseases, and increasing awareness of lacrimal drainage disorders are fueling demand for advanced treatment options. The country’s healthcare system supports the adoption of minimally invasive ophthalmic...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian